Project Number 1R01AG076565-01 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for First in Human Study of a Tau Self-Association Small Molecule Inhibitor in Healthy Volunteers Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) b. Tau Researcher and Organization Principal Investigator PICARD, MARTIN Principal Investigator First Name MARTIN Principal Investigator Last Name PICARD Awardee Organization OLIGOMERIX, INC Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-877: Early Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional) FY Overall Cost $1,582,308 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official CLARKE, AKANNI YAO
